Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival

There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell differentiation. Here, we found that the frequency of interleukin (IL)-22(+)IL-17(−)IL-13(+) T cells is significantly increased in peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lullo, Giulia, Marcatti, Magda, Heltai, Silvia, Brunetto, Emanuela, Tresoldi, Cristina, Bondanza, Attilio, Bonini, Chiara, Ponzoni, Maurilio, Tonon, Giovanni, Ciceri, Fabio, Bordignon, Claudio, Protti, Maria Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485827/
https://www.ncbi.nlm.nih.gov/pubmed/26155400
http://dx.doi.org/10.1080/2162402X.2015.1005460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485827/
https://www.ncbi.nlm.nih.gov/pubmed/26155400
http://dx.doi.org/10.1080/2162402X.2015.1005460

Ejemplares similares